Skip to main content
. 2021 Aug 25;10(9):2193. doi: 10.3390/cells10092193

Table 1.

Baseline characteristics of the total population and according to presence of CAD.

All (n = 287) No CAD (n = 69) Non-Significant CAD (n = 88) Significant CAD (n = 130) p-Value 1 p-Value 2 p-Value 3
Age (years) * 62.4 (40.1–87.2) 60.8 (43.8–80.6) 61.7 (40.1–79.6) 63.7 (40.9–87.2) 0.079 0.085 0.037
Sex; female, n (%) 102 (35.5) 44 (63.8) 32 (36.4) 26 (20.0) <0.001 <0.001 <0.001
BMI (kg/m2) 26.6 (24.7, 29.6) 26.8 (24.3, 30.4) 26.3 (24.7, 29.0) 26.6 (25.0, 30.0) 0.271 0.954 0.524
Diabetes, n (%) 56 (19.5) 15 (21.7) 12 (13.6) 29 (22.3) 0.248 0.593 0.927
Hypertension, n (%) 169 (58.9) 34 (49.3) 50 (56.8) 85 (65.4) 0.081 0.063 0.041
Resting heart rate (bpm) 68 (61, 77) 70 (62, 75) 70 (62, 80) 67 (59, 75) 0.076 0.630 0.189
Hypercholesterolemia, n (%) 231 (80.5) 42 (60.9) 71 (80.7) 118 (90.8) <0.001 <0.001 <0.001
Smoker, n (%) 4 52 (18.1) 39 (56.5) 54 (61.4) 83 (63.9) 0.602 0.348 0.391
HbA1c % 5.7 (5.4, 6.2) 5.7 (5.4, 6.2) 5.6 (5.4, 5.9) 5.7 (5.4, 6.3) 0.232 0.720 0.753
Creatinine (μmol/L) 79 (69, 89) 73.5 (66, 80.5) 78 (68, 88) 82 (73, 93) <0.001 <0.001 <0.001
Total cholesterol (mmol/L) 4.6 (3.9, 5.6) 5.3 (4.5, 6.2) 4.7 (3.9, 5.8) 4.3 (3.7, 5) <0.001 <0.001 <0.001
LDL (mmol/L) 2.6 (2.1, 3.5) 3.0 (2.4, 4.0) 2.6 (2.0, 3.6) 2.4 (2.0, 3.0) 0.001 0.002 <0.001
Medication, n (%)
Platelet inhibitor 5 209 (72.8) 29 (42.0) 63 (71.6) 117 (90.0) <0.001 <0.001 <0.001
ACEI/ARB 103 (35.9) 17 (24.6) 35 (39.8) 51 (39.2) 0.083 0.026 0.054
Betablocker 119 (41.5) 14 (20.3) 34 (38.6) 71 (54.6) <0.001 <0.001 <0.001
Calcium blocker 47 (16.3) 5 (7.3) 14 (15.9) 28 (21.5) 0.035 0.019 0.013
Statins 203 (70.7) 34 (49.3) 60 (68.2) 109 (83.9) <0.001 <0.001 <0.001

Variables are given as medians (25th, 75th percentile) unless stated otherwise. * Mean (min, max). 1 refers to the difference between the groups of CAD. 2 Refers to differences between no CAD and any CAD (non-significant CAD and significant CAD together). 3 refers to differences between no CAD and significant CAD. 4 Includes smokers and previous smokers. 5 Refer to the use of acetylsalisylic acid, dipyramidol or clopidogrel, or combinations of these. BMI = body mass index, bpm = beats per minute, LDL = low-density lipoprotein, ACEI = angiotensin-converting-enzyme inhibitor, ARB = angiotensin II receptor blocker.